LB Pharmaceuticals (LBRX) Cash Flow: Operating & Free Cash Flow

LB Pharmaceuticals Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for LB Pharmaceuticals Inc (LBRX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Operating Activities
Net Income	-25.21	-63.10	-6.28	-14.35
Depreciation & Amortization	0.32	0.09	0.00	0.00
Stock Based Compensation	4.19	3.16	0.30	0.43
Change in Working Capital	-13.65	3.31	-1.31	0.09
Change in Accounts Receivable	-0.27	0.11	-0.15	0.00
Change in Accounts Payable	-0.91	0.00	1.10	0.13
Change in Other Working Capital	0.15	0.31	-2.41	1.65
Other Operating Activities	0.15	0.31	-4.81	1.65
Net Cash from Operating Activities	-35.21	-53.05	-12.09	-2.73
Investing Activities
Capital Expenditures	-0.05	-0.77	-0.03	0.00
Purchases of Investments	-44.84	-29.75	-27.99	0.12
Sales/Maturities of Investments	5.00	53.75	6.00	0.12
Net Cash from Investing Activities	-39.89	23.23	-28.01	0.12
Financing Activities
Debt Repayment	0.00	0.00	0.73	25.01
Common Stock Issued	327.75	0.00	0.00	0.00
Other Financing Activities	-25.44	-1.71	-2.05	-2.95
Net Cash from Financing Activities	302.56	38.32	33.68	22.96
Summary
Effect of Forex Changes on Cash	-0.27	0.00	0.00	0.00
Net Change in Cash	227.47	8.50	-6.43	20.36
Cash at Beginning of Period	23.48	14.98	21.40	1.05
Cash at End of Period	250.94	23.48	14.98	21.40
Free Cash Flow	-35.26	-53.82	-12.12	-2.73
Supplemental Disclosures
Interest Paid	-	-	1.98	-
Income Taxes Paid	0.00	0.00	0.00	0.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About LB Pharmaceuticals Cash Flow

What is LB Pharmaceuticals's free cash flow?

LB Pharmaceuticals had negative free cash flow of $35.26M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$35.21M minus $52.00K of capital expenditures.

How much does LB Pharmaceuticals spend on capital expenditures?

LB Pharmaceuticals spent $52.00K on capital expenditures in fiscal 2025, compared with $769.00K a year earlier.

Does LB Pharmaceuticals pay dividends or buy back shares?

LB Pharmaceuticals's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition